Succinic Acid

Succinic Acid

SCHEMBL147079

CC(N)(O)CN.O=C(O)CCC(=O)O.O=C(O)CCC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.39
LMNA P02545 4/20 0.47
EGLN1 Q9GZT9 3/20 0.47
ALKBH5 Q6P6C2 1/20 0.47
SUCNR1 Q9BXA5 1/20 0.47
KDM4E B2RXH2 3/20 0.46
GABRR1 P24046 2/20 0.46
SLC15A2 Q16348 1/20 0.43
THRB P10828 3/20 0.42
KMT2A Q03164 3/20 0.42
GABRP O00591 3/20 0.42
GABRD O14764 3/20 0.42
GABRA1 P14867 3/20 0.42
GABRB1 P18505 3/20 0.42
GABRG2 P18507 3/20 0.42
GABRB3 P28472 3/20 0.42
GABRA5 P31644 3/20 0.42
GABRA3 P34903 3/20 0.42
GABRA2 P47869 3/20 0.42
GABRB2 P47870 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL28726920 0.83 KDM4E (0.44) LMNAKDM4ETHRBKMT2ACYP1A2
SCHEMBL774585 0.80
SCHEMBL7183027 0.79
Succinic Acid SCHEMBL28677195 0.76 ALDH1A1 (0.54) LMNAEGLN1ALKBH5SUCNR1KDM4E
Adipic Acid SCHEMBL11792741 0.76 LMNA (0.61) LMNATHRBKMT2ABLMNPSR1
Adipic Acid SCHEMBL8755769 0.76 LMNA (0.61) LMNATHRBKMT2ABLMNPSR1
Succinic Acid SCHEMBL13724115 0.76 ALDH1A1 (0.54) LMNAEGLN1ALKBH5SUCNR1KDM4E
Succinic Acid SCHEMBL19181068 0.75 EGLN1 (0.56) LMNAEGLN1ALKBH5SUCNR1KDM4E
Succinic Acid SCHEMBL22346309 0.74 LMNA (0.47) LMNAEGLN1ALKBH5SUCNR1KDM4E
SCHEMBL21776012 0.74 LMNA (0.47) LMNAEGLN1ALKBH5SUCNR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113817551-B Laundry soap containing cationic polymer 广州立白企业集团有限公司 2024-03-01 CN claimed
CN-109439474-B Cleaning soap containing cationic polymer and preparation method thereof 广州立白企业集团有限公司 2021-05-18 CN claimed
US-20180049958-A1 AGENT FOR IMPROVED OXIDATIVE LIGHTENING OF KERATINIC FIBRES HENKEL AG & CO. KGAA (DE) 2018-02-22 US claimed
US-20160331664-A1 AGENTS FOR GENTLY OXIDATIVELY LIGHTENING KERATIN-CONTAINING FIBERS HENKEL AG & CO. KGAA (DE) 2016-11-17 US claimed
EP-1489909-B1 TRANSITION METAL CHELATES AS SELECTIVE HERBICIDE NEUDORFF W GMBH KG (DE) 2016-11-02 EP claimed
EP-0819164-B2 DETERGENT COMPOSITION COMPRISING SOURCE OF HYDROGEN PEROXIDE AND PROTEASE ENZYME PROCTER & GAMBLE (US) 2013-03-13 EP claimed
US-7084102-B1 Mixture of clay minerals and metal compound; discoloration inhibition; tablet; fabric softening, laundering THE PROCTER & GAMBLE COMPANY (US) 2006-08-01 US claimed
EP-0819164-B1 DETERGENT COMPOSITION COMPRISING SOURCE OF HYDROGEN PEROXIDE AND PROTEASE ENZYME PROCTER & GAMBLE (US) 2005-07-27 EP claimed
EP-0836469-A4 BACTERICIDAL COMPOSITION PROCTER & GAMBLE (US) 1999-09-15 EP claimed
EP-0938290-A1 SHAMPOO COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1999-09-01 EP claimed
US-5755992-A MIXED WITH POLYMERIC DYE TRANSFER INHIBITOR; ANTISOILANT PRETREATMENT WASH THE PROCTER & GAMBLE COMPANY (US) 1998-05-26 US claimed
EP-0836469-A1 BACTERICIDAL COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1998-04-22 EP claimed
WO-1998004237-A1 SHAMPOO COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-02-05 WO claimed
WO-1997002010-A1 BACTERICIDAL COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1997-01-23 WO claimed
WO-1995029220-A1 DETERGENT COMPOSITIONS CONTAINING DIAMINE TETRACARBOXYLIC ACID OR SALTS THEREOF THE PROCTER & GAMBLE COMPANY (US) 1995-11-02 WO claimed
EP-0672749-A1 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1995-09-20 EP claimed
EP-4729046-A2 COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS The Procter & Gamble Company (US) 2026-04-22 EP disclosed
US-12606453-B2 Method for making and using anticorrosive material IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2026-04-21 US disclosed
EP-0672749-A1 Bleaching compositions THE PROCTER & GAMBLE COMPANY (US) 1995-09-20 EP disclosed
WO-1995012652-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1995-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606453-B2 Method for making and using anticorrosive material ELL, CA3, PCCA SLC6A2 3261/4885LMNA 1534/4885EGLN1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.